期刊文献+

新型磺酰类醛糖还原酶抑制剂的合成及活性研究

Synthesis and Inhibitory Activity of Sulfonyl Compounds as New Aldose Reductase Inhibitors
下载PDF
导出
摘要 以2,4-二甲苯胺为原料,设计并合成了一系列环外磺酰胺(酯)类衍生物,对目标化合物的醛糖还原酶(ALR2)抑制活性进行了测定,并利用分子对接方法研究了抑制剂与醛糖还原酶蛋白的结合模式.结果显示环外磺酰类化合物8a-d,12a-b,16a-b具有良好的体外醛糖还原酶抑制活性,分子模拟预测其能与酶蛋白的活性位点空腔较好结合.化合物8a-d是一类新型醛糖还原酶抑制剂,活性良好,并可作为先导化合物探索活性更高的醛糖还原酶抑制剂. A series of sulfonamide (ester) derivatives were designed and synthesized by using 2,4- dimethylaniline as the starting material. The in vitro inhibitory activities of the target compounds against aldose reductase were evaluated. Docking studies were performed to examine the manner by which newly prepared compounds interact with ALR2. It was found that sulfonyl compounds 8a-d, 12a-b, 16a-b show moderate inhibitory activities against aldose reductase and they interact with the ALR2 active site pocket in a good way. Compounds 8a-d are found as a new type of aldose reductase inhibitors with moderate activity and they can be used as lead compounds to explore ARIs with higher activity.
出处 《北京理工大学学报》 EI CAS CSCD 北大核心 2015年第6期656-660,共5页 Transactions of Beijing Institute of Technology
基金 国家自然科学基金资助项目(21272025)
关键词 醛糖还原酶抑制剂 磺酰类化合物 合成 生物活性 aldose reductase inhibitors sulfonyl compounds synthesis bioactivity
  • 相关文献

参考文献14

  • 1Diamond J. The double puzzle of diabetes[J]. Nature, 2003,423(6940) :599 - 602.
  • 2Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004,27(10) : 1047 - 1053.
  • 3Zimmet P Z, Alberti K G M M, Shaw J. Global and societal implications of the diabetes epidemic [J ]. Nature, 2001,414(6865) :782 - 787.
  • 4World Health Organization (WHO). Disease action now booklet[EB/OL]. [2015 - 02 - 06]. http://www, who. int/diabetes/actionnow/en/.
  • 5Humljan J, Kotnik M, Contreras-Martel C, et al. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme [ J ]. Journal of Medicinal Chemistry, 2008,51(23) :7486 - 7494.
  • 6Holloway M K, Hunt P, MeGaughey G B. Structure and modeling in the design of fl-and y-secretase inhibitors [J]. Drug Development Research, 2009, 70(2) :70 - 93.
  • 7Lee J, Song L, Terracina G, et al. Identification ofpresenilin 1-selective 7-secretase inhibitors with reconstituted γ-seeretase complexes[J]. Biochemistry, 2011,50(22) :4973 - 4980.
  • 8Silvestri R. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease[J]. Medicinal Research Reviews, 2009,29(2) :295 - 338.
  • 9MacMillan K S, Naidoo J, Liang J, et al. Development of proneurogenie, neuroprotective small molecules [J]. Journal of the American Chemical Society, 2011, 133(5) :1428 - 1437.
  • 10Chert X, Yang Y C, Ma B, et al. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold[J]. European Journal of Medicinal Chemistry, 2011,46 (5):1536- 1544.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部